Bayer faces fourth U.S. Roundup cancer trial in Monsanto’s hometown
(Reuters) – Bayer AG (BAYGn.DE) is set to face a fourth U.S. jury trial over allegations that its Roundup weed…
Bayer expects significant surge in number of U.S. glyphosate cases
FRANKFURT (Reuters) – Bayer expects the number of claims in the United States related to Roundup herbicide to have surged…
Bayer says October U.S. glyphosate trial delayed until February
FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker…
Bayer says October U.S. glyphosate trial delayed until February
FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker…
Inside drugmakers’ strategy to boost cancer medicines with ‘Lazarus effect’
(Reuters) – In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect”…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United…
Bayer in frame to win first EU nod for high-precision cancer drug
(Reuters) – Europe’s drug regulator has recommended approving Bayer’s Vitrakvi, putting the medicine on track to become the first in…
In Roundup case, U.S. judge cuts $2 billion verdict against Bayer to $86 million
(Reuters) – A California judge on Thursday reduced a $2 billion jury verdict, slashing the award for a couple who…
U.S. judge slashes Roundup jury award to $25.3 million from $80.3 million
FILE PHOTO: A logo of Bayer AG is pictured at the so called ‘Chempark’, the main plant and headquarters of…
Juror urges U.S. judge to uphold $80 million Roundup verdict against Bayer
(Reuters) – A juror who was part of a panel that delivered an $80 million award against Bayer AG after…
U.S. judge appoints Ken Feinberg mediator for Bayer Roundup settlement talks
(Reuters) – A U.S. judge on Wednesday appointed prominent attorney Kenneth Feinberg as mediator for court-mandated settlement talks in the…
U.S. judge appoints Ken Feinberg mediator for Bayer Roundup settlement talks
(Reuters) – A U.S. judge on Wednesday appointed prominent attorney Kenneth Feinberg as mediator for court-mandated settlement talks in the…
Bayer bets on ‘silver bullet’ defense in Roundup litigation; experts see hurdles
NEW YORK (Reuters) – Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits…
Bayer bets on ‘silver bullet’ defense in Roundup litigation; experts see hurdles
NEW YORK (Reuters) – Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits…
California jury hits Bayer with $2 billion award in Roundup cancer trial
(Reuters) – A California jury on Monday awarded more than $2 billion to a couple who claimed Bayer AG’s glyphosate-based…
U.S. jury says Bayer must pay $81 million to man in Roundup cancer trial
FILE PHOTO: Monsanto’s Roundup weedkiller atomizers are displayed for sale at a garden shop near Brussels, Belgium November 27, 2017.…
U.S. jury to determine liability, damages in Roundup cancer trial
SAN FRANCISCO (Reuters) – A lawyer for a man who said his cancer was caused by Bayer AG’s glyphosate-based weed…
U.S. jury orders Takeda to pay Bayer $155 million over hemophilia drug
(Reuters) – A U.S. jury has ordered Takeda Pharmaceutical Co’s Baxalta unit to pay Bayer AG $155.19 million for infringing…
U.S. jury orders Takeda to pay Bayer $155 million over hemophilia drug
(Reuters) – A U.S. jury has ordered Takeda Pharmaceutical Co’s Baxalta unit to pay Bayer AG $155.19 million for infringing…
Bayer cuts forecasts on Monsanto delay as lawsuits pile up
FRANKFURT (Reuters) – Bayer cut its earnings forecast on Wednesday due to delays to its $63 billion takeover of Monsanto,…
Bayer, J&J’s heart drug Xarelto fails trial to widen use
FRANKFURT (Reuters) – Bayer and Johnson & Johnson’s campaign to widen the market for its heart drug Xarelto hit a…
Bayer’s Monsanto faces 8,000 lawsuits on glyphosate
FRANKFURT (Reuters) – The number of U.S. lawsuits brought against Bayer’s (BAYGn.DE) newly acquired Monsanto has jumped to about 8,000,…
Bayer hits back at new Netflix medical device documentary
NEW YORK (Reuters) – Bayer AG disputed accusations in a new Netflix documentary that claims medical device makers and the…
Bayer launches $7 billion cash call to fund Monsanto deal
BERLIN (Reuters) – Bayer (BAYGn.DE) launched a 6 billion euros ($7 billion) rights issue on Sunday, a cornerstone of the…